Jaguar Gene Therapy
Mike is a pragmatic, outcome-driven leader with 25 years of varied legal experience in the healthcare industry ranging from large branded pharma, generic pharma, med device and gene therapy.
This person is not in any offices
Jaguar Gene Therapy
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. Led by the former AveXis leadership team and backed by Deerfield Management, a healthcare-specific investment firm, Jaguar brings streamlined R&D, manufacturing and clinical operations to accelerate development and potential approval of therapies for severe genetic diseases.